MAP2K7 and acute myeloid leukemia: In primary AML samples in which treatment with Pinometostat resulted in cell growth yielding sufficient RNA or protein, we also analyzed the impact of DOT1L inhibition on FLT3, PI3K/Akt, and MEK/ERK pathways by means of RT-PCR and immunoblotting.